Identification of human cancer antigens by SEREX

Tsutomu Okada, Yutaka Kawakami

研究成果: Article

抜粋

SEREX (serological identification of tumor antigens by recombinant cDNA expression cloning) is a powerful cDNA expression cloning technique for isolation of tumor antigens recognized by T cells using serum antibodies from cancer patients from whom it is difficult to raise tumor-reactive T cells. To efficiently identify tumor antigens, various modifications have been attempted for SEREX because of frequent isolation of antigens not associated with immune responses to tumor cells. These include use of a cDNA library made from testis, use of sera from patients who are immunized with autologous tumor-derived products who demonstrate tumor regression after treatment, and use of human IgG containing mice sera from immunodeficient mice implanted with human tumor tissues.

元の言語English
ページ(範囲)205-211
ページ数7
ジャーナルBiotherapy
18
発行部数3
出版物ステータスPublished - 2004 5 1

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

フィンガープリント Identification of human cancer antigens by SEREX' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Okada, T., & Kawakami, Y. (2004). Identification of human cancer antigens by SEREX. Biotherapy, 18(3), 205-211.